Search results
AbbVie Stock Dives As Cosmetic Sales Mar Its Third-Quarter Beat And Guidance Boost
Investor's Business Daily· 8 months agoAbbVie posted a nearly perfect third-quarter beat Friday, but AbbVie stock skidded on light...
AbbVie's Humira Downfall Is Swift As Biosimilars Hammer Away At Sales
Investor's Business Daily· 1 year agoAbbVie stock crumbled Thursday after the first approved biosimilar copycat to launch in the U.S....
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 9 months agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
AbbVie (ABBV) Q3 Earnings Beat, Shares Down Despite Raised View
Zacks via Yahoo Finance· 8 months agoAbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its...
AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales
Zacks via Yahoo Finance· 1 year agoAbbVie Inc. ABBV reported adjusted earnings of $3.60 per share for the fourth quarter of 2022,...
AbbVie (ABBV) Stock Moves -0.43%: What You Should Know
Zacks via Yahoo Finance· 1 year agoAbbVie (ABBV) closed at $145.65 in the latest trading session, marking a -0.43% move from the prior...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) closed the most recent trading day at $138.28, moving -0.63% from the previous trading...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 months agoAbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last...